ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 54

$612K Total Retail Price of All Prescriptions

Rank: 9 out of 54

200 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 200 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,265 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 491 491 1 3
TRAZODONE HCL 411 384 2 10
LISINOPRIL 373 355 3 6
LEVOTHYROXINE SODIUM 373 361 3 2
DONEPEZIL HCL 318 315 5 8
WARFARIN SODIUM 255 248 6 1
AMLODIPINE BESYLATE 216 216 7 4
MIRTAZAPINE 208 198 8 11
OMEPRAZOLE 207 207 9 9
SIMVASTATIN 191 189 10 5
METOPROLOL TARTRATE 165 163 11 7
RISPERIDONE 162 162 12 23
ESCITALOPRAM OXALATE 156 132 13 18
PANTOPRAZOLE SODIUM 156 154 13 33
LANTUS 120 109 15 30
CITALOPRAM HBR 116 115 16 17
ATORVASTATIN CALCIUM 116 104 16 15
OXYCODONE HCL 116 116 S2 16 57
NAMENDA 112 112 19 13
SERTRALINE HCL 106 93 20 12
HYDROCHLOROTHIAZIDE 106 106 20 20
ATENOLOL 103 103 22 24
QUETIAPINE FUMARATE 98 75 23 21
TRAMADOL HCL 97 97 24 32
OXYBUTYNIN CHLORIDE ER 95 95 25 62
TAMSULOSIN HCL 93 93 26 25
ALENDRONATE SODIUM 92 92 27 31
CARVEDILOL 89 89 28 36
POTASSIUM CHLORIDE 86 86 29 22
GABAPENTIN 81 76 30 16
DIOVAN 76 76 31 29
PREDNISONE 73 68 32 34
RANITIDINE HCL 73 69 32 50
PRAVASTATIN SODIUM 72 69 34 27
ISOSORBIDE MONONITRATE ER 71 70 35 41
ALLOPURINOL 71 71 35 52
METFORMIN HCL 70 54 37 19
ADVAIR DISKUS 69 69 38 42
DIVALPROEX SODIUM 68 40 39 28
PAROXETINE HCL 68 68 39 69
METOPROLOL SUCCINATE 67 67 41 14
GLIPIZIDE 65 53 42 47
IPRATROPIUM-ALBUTEROL 61 61 43 54
DILTIAZEM 24HR CD 61 61 43 94
KLOR-CON M20 60 60 45 68
CLOPIDOGREL 56 56 46 38
LIDODERM 55 55 47 44
OLANZAPINE 53 53 48 43
VOLTAREN 51 51 49 179
ABILIFY 51 34 49 80
SEROQUEL 50 41 51 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.